Clinical Trials Browser

Advanced Breast Cancer

Carcinoma, Non-Small-Cell Lung

Adenocarcinoma Of Esophagus

Triple Negative Breast Neoplasms

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms

Carcinoma, Non-Small-Cell Lung, Respiratory Tract Neoplasms

Squamous Cell Carcinoma of Head and Neck, Carcinoma, Hypopharyngeal Neoplasms, Laryngeal Neoplasms, Mouth Neoplasms, Oropharyngeal Neoplasms

Pancreatic Cystic Neoplasm

Lung Diseases, Interstitial

Triple Negative Breast Neoplasms

Breast Neoplasms

Advanced Squamous Non-Small Cell Lung Cancer

Ovarian Neoplasms

Squamous Cell Carcinoma of Head and Neck, Laryngeal Neoplasms, Mouth Neoplasms

Ovarian Neoplasms

Carcinoma, Squamous Cell

Multiple Myeloma, Triple Negative Breast Neoplasms

Gastric Cancer Peritoneal Metastases

Carcinoma, Non-Small-Cell Lung, Neoplasms, Disease Progression

Esophageal Neoplasms

Triple Negative Breast Neoplasms

PDAC - Pancreatic Ductal Adenocarcinoma

Stomach Neoplasms

Uterine Cervical Neoplasms, Drug Hypersensitivity, Ovarian Neoplasms, Endometrial Neoplasms

Stage III and IV Ovarian Cancer

Esophageal Neoplasms

Pancreatic Intraductal Neoplasms

Esophageal Neoplasms, Stomach Neoplasms

Uterine Cervical Neoplasms

Triple Negative Breast Neoplasms

Recurrence, Endometrial Neoplasms

Advanced Esophageal Carcinoma

Thyroid Neoplasms

Squamous Cell Carcinoma of Head and Neck

Solid Tumor Cancer

Carcinoma, Non-Small-Cell Lung

Platinum-sensitive Relapsed Ovarian Cancer

Uterine Cervical Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Ovarian Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Neoplasms, Endometrial Neoplasms

Squamous Cell Carcinoma of Head and Neck, Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Endometrial Neoplasms

Carcinoma, Non-Small-Cell Lung

Stomach Neoplasms

Advanced Non-squamous Non-small-cell Lung Cancer

Esophageal Neoplasms

Clinical Trials

Metronomic Oral Paclitaxel Monotherapy and Combined Immunotherapy for Advanced HER2-Negative Breast Cancer: A Two-Stage Dose Exploration and Expansion Trial

Oral Paclitaxel as Neoadjuvant Therapy in Elderly NSCLC: A Phase II Trial

Futibatinib With Paclitaxel and Ramucirumab for the Treatment of Locally Advanced or Unresectable Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma

Cancer Immunotherapeutic (PCI) Strategy in Triple Negative Breast Cancer Patients

Losartan and Paclitaxel in Platinum Resistant Ovarian Cancer

MIGRANT

Comparing Radiation Plus Cetuximab to Radiation Plus Chemotherapy in People With Head and Neck Cancer Who Cannot Receive Cisplatin

ERASE-Chemo

Treatment in Patients With Advanced Non-Small Cell Lung Carcinoma and Interstitial Lung Disease

Gemcitabine vs Paclitaxel in Caribbean Women of African Ancestry With Metastatic Triple-Negative Breast Cancer

A Single-arm, Prospective, Phase II Clinical Study of the Combination of Entinostat and Oral Paclitaxel in the Treatment of HR+HER2- Advanced Breast Cancer

CECYDE

Iparomlimab and Tuvonralimab (QL1706) Combined With Standard Chemotherapy or Combined With Intraperitoneal Perfusion Chemotherapy and Olaparib as Neoadjuvant Therapy for Advanced Ovarian Cancer

NeoCamre-HN

The Efficacy and Safety of Paclitaxel Monotherapy Versus Paclitaxel-Carboplatin Combination as Neoadjuvant Chemotherapy in Advanced Ovarian Cancer With High PARK2 Expression

A Trial of Locoregionally Advanced Squamous Cell Carcinoma of The Head and Neck

Systemic Anti-Cancer Therapy Dose Modifications for Individuals With Duffy Null Phenotype

A Prospective, Phase II Clinical Study of HIPEC Combined With NIPS and Tislelizumab Conversion Therapy for Gastric Cancer With Peritoneal Metastasis With Positive Cytology Alone or PCI Score ≤10

HYPERBOLIC

MRD2START

The Neoadjuvant Treatment of Early High-risk Triple Negative Breast Cancer With HRD Positive With Iparomlimab and Tuvonralimab Combined With Olaparib and Paclitaxel

PANORAMIX

Phase II Study of QL1706 Combined With Paclitaxel and Bevacizumab for Second-Line Immune Rechallenge in Gastric Cancer

Proactive Immune Tolerance Induction in Chemotherapy for Gynecologic Cancer

Ivonescimab (AK112) Plus Paclitaxel as Second-line Therapy in Patients With Advanced G/GEJ Cancer

Total Neoadjuvant 6 Cycles of Chemotherapy Versus 3 Cycles in Partial Responder Patients Diagnosed With Epithelial Ovarian Cancer

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

JS207 Combined With Chemotherapy in Subjects With Stage II-III NSCLC

Feasibility Trial of EUS-PCA in IPMN Pancreatic Cysts

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Comparative Study of Adjuvant Therapy for Postoperative Cervical Gastric-type Adenocarcinoma

Non-Inferiority Study on MRNA-lncRNA Model in Low-Risk Triple-Negative Breast Cancer Patients

QL1706 Combined with Chemotherapy in the Treatment of Recurrent or Metastatic Endometrial Cancer

A Phase II Clinical Study to Evaluate the Safety, Pharmacokinetic Profile, and Preliminary Efficacy of IMM2510 in Combination with Chemotherapy As First-line Treatment in Subjects with Non-small Cell Lung Cancer or Triple-negative Breast Cancer

A Prospective, Randomized, Open, Phase II Clinical Study of Chidamide in Combination with Camrelizumab and Apatinib for Advanced Esophageal Cancer

Efficacy of Organoid-Based Chemotherapy Drug Precision Screening to Guide Treatment for Thyroid Cancer

Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC

EF-001

Neoadjuvant/Adjuvant Tislelizumab Combined With Anlotinib and Platinum Doublet Chemotherapy With Resectable NSCLC

Adebrelimab Plus Chemotherapy, Bevacizumab and Fluzoparib in Platinum-Sensitive Relapsed Ovarian Cancer

Nab-Paclitaxel Plus Cisplatin With Concurrent Radiotherapy for Patients With Locally Advanced Cervical Cancer: A Multicentre, Single-arm, Phase II Trial.

Neoadjuvant Pembrolizumab, Carboplatin and Paclitaxel in Triple-negative Breast Cancer

Fasting Mimicking Diet (FMD) in Conjunction With Chemotherapy in Advanced Ovarian Cancer

KEYPARTNER

Tislelizumab in Combination With Chemotherapy as a Neoadjuvant Treatment for Advanced Endometrial Cancer

Myeloprotection With Trilaciclib in Pan-cancer Population

Adebrelimab Plus Chemotherapy as Neoadjuvant Therapy in Resectable NSCLC Harboring Driver Gene Mutations

Anlotinib, TQB2450 (PD-L1 Inhibitor), and Albumin-bound Paclitaxel Regimens in the Treatment of GC/GEJA

Efficacy and Safety of Nab-paclitaxel-Lenvatinib-Pembrolizumab as Second-line Treatment in Advanced NSCLC Patients

Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinoma